Literature DB >> 18054976

Characterization of a novel psi-conotoxin from Conus parius Reeve.

Arturo O Lluisma1, Estuardo López-Vera, Grzegorz Bulaj, Maren Watkins, Baldomero M Olivera.   

Abstract

The M-superfamily of conotoxins currently comprises three major groups of peptides (the mu-, kappaMu-, and psi-families) that share a key structural characteristic, the six-cysteine motif CC-C-C-CC, but differ with respect to their molecular targets. The psi-family consists of M-superfamily conotoxins that are nicotinic acetylcholine receptor (nAChR) antagonists. To date, only two psi-conotoxins, PIIIE and PIIIF, are known, both of which were isolated from a single Conus species, Conus purpurascens. In this paper, we report the discovery and initial characterization of a psi-conotoxin from another Conus species, Conus parius, which we designated as PrIIIE. Its amino acid sequence, inferred from a cloned cDNA, differed significantly from those of PIIIE and PIIIF. Its bioactivity was investigated by using the synthetic form of the peptide in mice and fish bioassays. At 2.5 nmol, the synthetic peptide induced flaccid paralysis in goldfish in ca. 4 min but did not induce any remarkable behavior in mice (after i.c. and i.p. injection of up to 10 nmol of peptide) and did not block action potential in directly stimulated frog muscle preparations. Electrophysiological experiments carried out to measure inhibition of ion currents through mouse nAChR receptors expressed in oocytes revealed that PrIIIE (IC(50) approximately 250 nM) was significantly more potent than PIIIE (IC(50) approximately 7000 nM) and that PrIIIE showed higher inhibition potency against the adult-type than the fetal-type nAChR. In similar electrophysiological assays, PrIIIE showed no inhibitory effects against the mouse muscle subtype Na(+) channel isoform Na(v) 1.4. The discovery of this psi-conotoxin from a Conus species that belongs to the subgenus Phasmoconus, which is distinct from and larger than the clade in which C. purpurascens belongs, suggests that greater structural and functional diversity of psi-conotoxins remains to be discovered from the members of this subgenus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054976      PMCID: PMC2669105          DOI: 10.1016/j.toxicon.2007.07.009

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

Review 1.  Sodium channel toxins--receptor targeting and therapeutic potential.

Authors:  Robert J French; Heinrich Terlau
Journal:  Curr Med Chem       Date:  2004-12       Impact factor: 4.530

2.  Oxidative folding of conotoxins sharing an identical disulfide bridging framework.

Authors:  Erika Fuller; Brad R Green; Phil Catlin; Olga Buczek; Jacob S Nielsen; Baldomero M Olivera; Grzegorz Bulaj
Journal:  FEBS J       Date:  2005-04       Impact factor: 5.542

3.  A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.

Authors:  G E Cartier; D Yoshikami; W R Gray; S Luo; B M Olivera; J M McIntosh
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

4.  Definition of the M-conotoxin superfamily: characterization of novel peptides from molluscivorous Conus venoms.

Authors:  Gloria P Corpuz; Richard B Jacobsen; Elsie C Jimenez; Maren Watkins; Craig Walker; Clark Colledge; James E Garrett; Owen McDougal; Wenqin Li; William R Gray; David R Hillyard; Jean Rivier; J Michael McIntosh; Lourdes J Cruz; Baldomero M Olivera
Journal:  Biochemistry       Date:  2005-06-07       Impact factor: 3.162

5.  Predominant interactions between mu-conotoxin Arg-13 and the skeletal muscle Na+ channel localized by mutant cycle analysis.

Authors:  N S Chang; R J French; G M Lipkind; H A Fozzard; S Dudley
Journal:  Biochemistry       Date:  1998-03-31       Impact factor: 3.162

6.  Standardization of the rat paw formalin test for the evaluation of analgesics.

Authors:  H Wheeler-Aceto; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 7.  Conus venoms: a rich source of novel ion channel-targeted peptides.

Authors:  Heinrich Terlau; Baldomero M Olivera
Journal:  Physiol Rev       Date:  2004-01       Impact factor: 37.312

  7 in total
  11 in total

1.  Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.

Authors:  Sulan Luo; Dongting Zhangsun; Peta J Harvey; Quentin Kaas; Yong Wu; Xiaopeng Zhu; Yuanyan Hu; Xiaodan Li; Victor I Tsetlin; Sean Christensen; Haylie K Romero; Melissa McIntyre; Cheryl Dowell; James C Baxter; Keith S Elmslie; David J Craik; J Michael McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

2.  Structure-function elucidation of a new α-conotoxin, Lo1a, from Conus longurionis.

Authors:  Eline K M Lebbe; Steve Peigneur; Mohitosh Maiti; Prabha Devi; Samuthirapandian Ravichandran; Eveline Lescrinier; Chris Ulens; Etienne Waelkens; Lisette D'Souza; Piet Herdewijn; Jan Tytgat
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

3.  A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors.

Authors:  Philippe Favreau; Evelyne Benoit; Henry G Hocking; Ludovic Carlier; Dieter D' hoedt; Enrico Leipold; René Markgraf; Sébastien Schlumberger; Marco A Córdova; Hubert Gaertner; Marianne Paolini-Bertrand; Oliver Hartley; Jan Tytgat; Stefan H Heinemann; Daniel Bertrand; Rolf Boelens; Reto Stöcklin; Jordi Molgó
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 4.  The M-superfamily of conotoxins: a review.

Authors:  Reed B Jacob; Owen M McDougal
Journal:  Cell Mol Life Sci       Date:  2009-08-25       Impact factor: 9.261

Review 5.  Conotoxins that confer therapeutic possibilities.

Authors:  Magbubah Essack; Vladimir B Bajic; John A C Archer
Journal:  Mar Drugs       Date:  2012-06-04       Impact factor: 6.085

6.  Characterization of a novel Conus bandanus conopeptide belonging to the M-superfamily containing bromotryptophan.

Authors:  Bao Nguyen; Jean-Pierre Le Caer; Gilles Mourier; Robert Thai; Hung Lamthanh; Denis Servent; Evelyne Benoit; Jordi Molgó
Journal:  Mar Drugs       Date:  2014-06-05       Impact factor: 5.118

Review 7.  Conotoxins targeting nicotinic acetylcholine receptors: an overview.

Authors:  Eline K M Lebbe; Steve Peigneur; Isuru Wijesekara; Jan Tytgat
Journal:  Mar Drugs       Date:  2014-05-22       Impact factor: 5.118

Review 8.  Conotoxin gene superfamilies.

Authors:  Samuel D Robinson; Raymond S Norton
Journal:  Mar Drugs       Date:  2014-12-17       Impact factor: 5.118

Review 9.  From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins.

Authors:  Aida Verdes; Prachi Anand; Juliette Gorson; Stephen Jannetti; Patrick Kelly; Abba Leffler; Danny Simpson; Girish Ramrattan; Mandë Holford
Journal:  Toxins (Basel)       Date:  2016-04-19       Impact factor: 4.546

10.  A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily.

Authors:  Sulan Luo; Sean Christensen; Dongting Zhangsun; Yong Wu; Yuanyan Hu; Xiaopeng Zhu; Sandeep Chhabra; Raymond S Norton; J Michael McIntosh
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.